Latest S-1 registration statements

FreeCast, Inc. is preparing for a direct listing on the Nasdaq Global Market, registering 19.78 million Class A common shares for resale, while reporting reduced net losses and significant ad revenue growth, but faces ongoing 'going concern' doubts and a shareholder lawsuit.

Terra Innovatum Global N.V., a micro modular nuclear solutions company, has successfully completed its business combination with GSR III Acquisition Corp. and commenced trading on Nasdaq under the symbol NKLR.

Daedalus Special Acquisition Corp. filed a Rule 462(b) registration statement to offer an additional 2,875,000 units, each comprising one Class A ordinary share and one-fourth of a redeemable warrant.

Focus Universal Inc. files an S-1 registration statement for the resale of up to 10,558,975 shares of common stock by selling stockholders, following a $7 million Series B Preferred Stock private placement.

APPlife Digital Solutions, an aftermarket auto parts e-commerce firm, filed an S-1 registration statement to register shares for resale and to facilitate a $15 million equity purchase agreement with C/M Capital Master Fund LP, amidst ongoing financial challenges and a going concern warning.

Polomar Health Services, Inc. filed an amendment to its S-1 registration statement, detailing offering expenses, indemnification policies, and recent unregistered stock issuances.

Charging Robotics Inc. filed an S-1/A registration statement for the resale of up to 7,928,852 shares of common stock by selling stockholders, contingent on its planned uplisting to the Nasdaq Capital Market.

Guident Corp. filed an S-1/A registration statement for an underwritten public offering of 1,704,545 shares of common stock, aiming for a Nasdaq listing and an estimated price range of $7.80 to $9.80 per share.

First Choice Healthcare Solutions is undergoing a strategic transformation, shifting from orthopedic services to a national network of primary care and wellness clinics, supported by a $12 million public offering.

Andersen Group Inc. files for an initial public offering of 11 million Class A common shares at $14-$16, revealing a complex UP-C structure and significant obligations to existing owners.

Silicon Valley Acquisition Corp., a newly formed SPAC, filed an amended registration statement for its $200 million initial public offering, targeting high-growth sectors like fintech, AI, and energy transition.

GRI Bio, Inc. announces a new public offering of common stock and warrants to raise up to $10 million, alongside positive topline Phase 2a clinical trial results for its lead IPF candidate, GRI-0621, despite ongoing financial challenges and Nasdaq non-compliance.

Ethos Technologies Inc., a digital life insurance platform, has filed an S-1/A registration statement for its initial public offering, highlighting significant revenue growth and recent GAAP profitability.

Klotho Neurosciences, Inc. filed an S-1 registration statement for the resale of up to 35 million shares of common stock by existing selling stockholders, including shares convertible from Series C Preferred Stock.

Biofrontera Inc. files an S-1 registration statement for the resale of 4,000,640 common shares by selling stockholders, with no proceeds going to the company.

Polomar Health Services, a compounding pharmacy, reported significant losses and negative working capital as it transitions its business model and pursues a merger with Altanine Inc., which is expected to give Altanine shareholders 80% ownership of the combined entity.

Inspire Veterinary Partners reports reduced net losses and improved cash flow from operations, but faces imminent Nasdaq delisting and ongoing 'going concern' doubts.

CERO Therapeutics Holdings, Inc. filed an S-1 registration statement for the resale of up to 729.6 million common shares by Keystone Capital Partners, LLC, following its delisting from Nasdaq to OTCQB.

Mitesco, Inc. is undergoing a significant business model transformation, pivoting from unprofitable medical clinics to data center services and AI software development, while grappling with substantial debt and a going concern warning.

Lexaria Bioscience Corp. filed an S-1/A registration statement for the resale of up to 2.76 million common shares by selling stockholders, with potential proceeds from warrant exercises earmarked for R&D.

Amatuhi Holdings, a Japanese provider of disability care group homes, files for an initial public offering of 1,000,000 shares on the Nasdaq Capital Market.

Smith Micro Software, Inc. has filed an S-1 registration statement to allow selling stockholders to resell up to 9.1 million shares of common stock, following several recent capital raises and ongoing Nasdaq minimum bid price compliance issues.

Blink Charging Co. is offering up to 14,814,814 shares of common stock at an assumed price of $1.35 per share to fund the expansion of its DC Fast Charging network.

Angel Studios, Inc. filed a Pre-Effective Amendment No. 2 to its Form S-3 registration statement to register for resale up to 10,042,523 shares of common stock by selling securityholders.

QuasarEdge Acquisition Corporation aims to raise $69 million through an initial public offering to pursue a business combination.

TGE Value Creative Solutions Corp, a blank check company, filed an amended S-1 registration statement for its $150 million initial public offering, targeting media, entertainment, and lifestyle sectors.

AIxCrypto Holdings, Inc. files S-1 for the resale of 18.1 million common shares by selling stockholders, signaling a strategic shift to cryptocurrency treasury operations and addressing Nasdaq compliance.

Reeds Inc. has filed an amendment to its S-1 registration statement, outlining the Warrant Agent Agreement with Transfer Online, Inc. for its upcoming public offering of common stock and warrants.

Hillhouse Frontier Holdings Inc. filed an S-1/A for its initial public offering, aiming to raise capital for its U.S.-to-China luxury vehicle export business and new car subscription service, despite recent revenue declines and significant operational risks.

Aspire Biopharma Holdings, Inc. reports significant net losses and going concern doubt, while facing Nasdaq delisting and substantial shareholder dilution from recent financing activities.